Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience
Ehrlich, C.E.; Einhorn, L.; Stehman, F.B.; Blessing, J.
Clinics in Obstetrics and Gynaecology 10(2): 325-335
1983
ISSN/ISBN: 0306-3356 PMID: 6688562 Document Number: 198106
Document emailed within 1 workday
Related Documents
Ohara, N.; Teramoto, K. 2000: Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen. Case report Clinical and Experimental Obstetrics and Gynecology 27(2): 123-124Ikeda, I.; Shuin, T.; Yao, M.; Kubota, Y.; Hosaka, M. 1993: New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases Hinyokika Kiyo. Acta Urologica Japonica 39(3): 237-242
Sevelda, P.; Dittrich, C.; Salzer, H.; Pateisky, N.; Spona, J. 1986: Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125 Cancer Detection and Prevention 9(5-6): 521-528
Suwannarurk, K.; Thaweekul, Y.; Mairaing, K.; Poomtavorn, Y.; Tangtiang, K.; Piyawang, W.; Bhamarapravatana, K. 2015: Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report Journal of the Medical Association of Thailand 98 Suppl. 3: S121-S125
Pizzocaro, G.; Milani, A.; Piva, L.; Faustini, M.; Spino, E. 1991: Methotrexate, vinblastine, adriamycin and cisplatin versus methotrexate and cisplatin in advanced urothelial cancer. A randomized study European Urology 20(2): 89-92
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15
Tokunaga, A.; Onda, M.; Mizutani, T.; Miyamoto, M.; Nomura, T.; Hayashi, H.; Kiyama, T.; Umehara, M.; Nishi, K.; Andoh, T. 1989: Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(12): 3713-3718
Onnis, A.; Marchetti, M.; Piazza, M. 1993: Clinical experience in gynaecological cancer management. D) Ovarian tumors--non-epithelial: report from the Gynaecological Institute of Padua University European Journal of Gynaecological Oncology 14(1): 5-17
Eagan, R.T.; Lee, R.E.; Frytak, S.; Scott, M.; Ingle, J.N.; Creagan, E.T.; Nichols, W.C. 1981: Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer Cancer Clinical Trials 4(4): 381-388
Krommer, K. 1992: Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University Orvosi Hetilap 133(19): 1151-1158
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Yasuda, T.; Kabuto, T.; Ishiguro, S.; Nakano, H.; Nakamori, S.; Ohigashi, H.; Hiratsuka, M.; Kameyama, M.; Sasaki, Y.; Ishikawa, O. 1995: Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1538-1541
Huanchun, Y.; Shulan, Z.; Jing, L. 2009: Genetic imbalance related to cisplatin-based chemoresistance in epithelial ovarian cancer European Journal of Gynaecological Oncology 30(2): 181-185
Olawaiye, A.B.; Godoy, H.E.; Shahzad, M.M.K.; Rauh-Hain, J.A.; Lele, S.B.; Odunsi, K. 2012: Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer European Journal of Gynaecological Oncology 33(5): 477-479
Zhao, J. 1985: Cisplatin or combined cisplatin and 60Co radiation in the treatment of advanced lung cancer--report of 145 cases Zhonghua Zhong Liu Za Zhi 7(4): 283-285
Soonthornthum, T.; Suraseraneewong, V.; Kengsakol, K.; Wijaithum, K.; Kasemsan, P.; Prommatt, S. 2007: Thrombocytosis in advanced epithelial ovarian cancer Journal of the Medical Association of Thailand 90(8): 1495-1500
Vogl, S.E.; Berenzweig, M.; Kaplan, B.H.; Moukhtar, M.; Bulkin, W. 1979: The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) Cancer Treatment Reports 63(2): 311-317
Deng, C.; Huang, R.; Lian, L. 1996: Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer Zhonghua Fu Chan Ke Za Zhi 31(3): 159-162
Ivanov, S.; Kovachev, E.; Kolev, N.; Bechev, B.; Kolev, N. 2016: Primary Cytoreductive Surgery versus Neoadjuvant Chemotherary in Treatment of Advanced Ovarian Cancer (Stage Iii C-Iv). our and Foreign Experience Akusherstvo i Ginekologiia 55 Suppl 1 Pt 1: 16-19
Yildirim, Y.; Sanci, M. 2004: The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer Archives of Gynecology and Obstetrics 272(1): 31-34